C. ADDITIONAL LABELLING FOR AUTHORISED INVESTIGATIONAL MEDICINAL PRODUCTS

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

In accordance with Article 67(2), the following particulars shall appear on the immediate and the outer packaging: name of the main contact; clinical trial reference code allowing identification of the clinical trial site, investigator, sponsor and subject; ’For clinical trial use only’ or similar wording.

← anx_VI__cpt_2__point_6__point_i__text_1 · All articles · 7. →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.